PMID- 11572800 OWN - NLM STAT- MEDLINE DCOM- 20011204 LR - 20190709 IS - 0022-0795 (Print) IS - 0022-0795 (Linking) VI - 171 IP - 1 DP - 2001 Oct TI - Administration of bovine, porcine and equine growth hormone to the horse: effect on insulin-like growth factor-I and selected IGF binding proteins. PG - 163-71 AB - This study investigated the biochemical effects of administration of three types of recombinant growth hormone (GH; somatotropin) to the Thoroughbred horse. Equine or bovine or porcine GH was administered at a recommended dosage to 3-5-year old Thoroughbred geldings, for up to 21 days. It was shown that, in addition to equine GH, bovine and porcine GH were active in the horse; however, porcine GH caused injection-site reactions that were so serious that administration had to be terminated. The concentrations of a range of GH-related serum protein markers were determined before, during and after the administration period. Because of the short half-life of GH itself, the objective was to identify GH-related markers that showed changes in concentration and which could be used as indicators of the abuse of these hormones. Among the possible markers identified, serum total insulin-like growth factor (IGF)-I was shown to be the most promising, increasing to 270% of the basal concentration for equine GH administration. After GH administration, IGF-I took longer to attain baseline concentrations than the time required for GH concentrations to recover to normal. The concentration obtained from the administration significantly exceeded natural concentrations for IGF-I, as was determined from a population of more than 2000 Thoroughbred horses in three continents. The concentrations of serum free IGF-I and IGF binding protein 3 (IGFBP-3) were also shown to be significantly affected by equine and bovine GH. FAU - De Kock, S S AU - De Kock SS AD - The Laboratory of the Jockey Club of Southern Africa, PO Box 74439, Turffontein 2140, South Africa. FAU - Rodgers, J P AU - Rodgers JP FAU - Swanepoel, B C AU - Swanepoel BC FAU - Guthrie, A J AU - Guthrie AJ LA - eng PT - Journal Article PL - England TA - J Endocrinol JT - The Journal of endocrinology JID - 0375363 RN - 0 (Biomarkers) RN - 0 (Insulin-Like Growth Factor Binding Protein 3) RN - 0 (Insulin-Like Growth Factor Binding Proteins) RN - 12629-01-5 (Human Growth Hormone) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 9002-72-6 (Growth Hormone) SB - IM MH - Animals MH - Biomarkers/blood MH - Cattle MH - Growth Hormone/*pharmacology MH - Horses/*metabolism MH - Human Growth Hormone/pharmacology MH - Immunoradiometric Assay MH - Insulin-Like Growth Factor Binding Protein 3/blood MH - Insulin-Like Growth Factor Binding Proteins/blood/*metabolism MH - Insulin-Like Growth Factor I/analysis/*metabolism MH - Male MH - Orchiectomy MH - Random Allocation MH - Species Specificity MH - Swine EDAT- 2001/09/27 10:00 MHDA- 2002/01/05 10:01 CRDT- 2001/09/27 10:00 PHST- 2001/09/27 10:00 [pubmed] PHST- 2002/01/05 10:01 [medline] PHST- 2001/09/27 10:00 [entrez] AID - JOE04338 [pii] AID - 10.1677/joe.0.1710163 [doi] PST - ppublish SO - J Endocrinol. 2001 Oct;171(1):163-71. doi: 10.1677/joe.0.1710163.